Дэниэл Амен - Великолепный мозг в любом возрасте

Neal, E. G., H. Chaffe, R. H. Schwartz, et al. 2008. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurology 7(6): 500–506.

Аутизм

Evangeliou, A., I. Vlachonikolis, H. Mihailidou, et al. 2003. Application of a ketogenic diet in children with autistic behavior: pilot study. Journal of Child Neurology 18(2): 113–118.

Поведение

Murphy, P, S. S. Likhodii, M. Hatamian, et al. 2005. Effect of the ketogenic diet on the activity level of Wistar rats. Pediatric Research 57(3): 353–357.

Pulsifer, M. B., J. M. Gordon, J. Brandt, et al. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Developmental Medicine & Child Neurology 43(5): 301–306.

Биполярное расстройство

El — Mallakh, R. S., and M. E. Paskitti. 2001. The ketogenic diet may have moodstabilizing properties. Medical Hypotheses 57(6): 724–726.

Yaroslavsky, Y., Z. Stahl, and R. H. Belmaker. 2002. Ketogenic diet in bipolar illness. Bipolar Disorders 4(1): 75.

Жирные кислоты омега-3/рыбий жир и депрессия

Conklin, S. М., S. В. Manuck, J. К. Yao, et al. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosomatic Medicine 69(9): 932–934.

Grenyer, В. Е, Т Crowe, В. Meyer, et al. 2007. Fish oil supplementation in the treatment of major depression: a randomised double- blind placebocontrolled trial. Progress in Neuropsychopharmacology and Biological Psychiatry 31(7): 1393–1396.

Stoll, A. L., C. A. Locke, L. B. Marangell, et al. 1999. Omega-3 fatty acids and bipolar disorder: A review. Prostaglandins, Leukotrienes & Essential Fatty Acids 60(5–6): 329–337.

Валериана

Balderer, G., and A. A. Borbely. 1985. Effect of valerian on human sleep. Psychopharmacology 87(4): 406–409.

Coxeter, P. D., P. J. Schluter, H. L. Eastwood, et al. 2003. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n- of- 1 trials. Complementary Therapies in Medicine 11(4): 215–222.

Diaper, A., and I. Hindmarch. 2004. A double- blind, placebo- controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep- disturbed older adults. Phytotherapy Research 18(10): 831–836.

Kuhlmann, J., W. Berger, H. Podzuweit, et al. 1999. The influence of valerian treatment on «reaction time, alertness and concentration» in volunteers. Pharmacopsychiatry 32(6): 235–241.

Витамин D и депрессия

Armstrong, D. J., G. K. Meenagh, I. Bickle, et al. 2007. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clinical Rheumatology 26(4): 551–554.

Berk, M., К. M. Sanders, J. A. Pasco, et al. 2007. Vitamin D deficiency may play a role in depression. Medical Hypotheses 69(6): 1316–1319.

Wilkins, С. Н., Y. I. Sheline, С. М. Roe, et al. 2006. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. American Journal of Geriatric Psychiatry 14(12): 1032–1040.

Гинкго билоба

Burns, N., J. Bryan, and T. Nettelbeck. 2006. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults. Human Psychopharmacology 21(1): 27–37.

Dodge, H., T. Zitzelberger, B. Oken, et al. 2008. A randomized placebo-controlled trial of ginkgo biloba for the prevention of cognitive decline. Neurology 70(19): 1809–1817.

Hartley, D., L. Heinze, S. Elsabagh, et al. 2003. Effects on cognition and mood in postmenopausal women of 1- week treatment with Ginkgo biloba. Pharmacology Biochemistry and Behavior 75(3): 711–720.

Le Bars, P. L. 2003. Response patterns of EGb 761 in Alzheimer’s disease: influence of neuropsychological profiles. Pharmacopsychiatry 36(Suppl. 1): S50-55.

Le Bars, P. L., and J. Kastelan . 2000. Efficacy and safety of a Ginkgo biloba extract. Public Health Nutrition 3(4A): 495–499.

Mix, J., and W. Crews. 2002. A double- blind, placebo- controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: Neuropsychological findings. Human Psychopharmacology 17(6): 267–277.

Nathan, P, S. Tanner, J. Lloyd, et al. 2004. Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humans. Human Psychopharmacology 19(2): 91–96.

Singh, В., Н. Song, X. Liu, et al. 2004. Dangshen (Codonopsis pilosula) and Bai guo (Ginkgo biloba) enhance learning and memory. Alternative Therapies in Health & Medicine 10(4): 52–56.

Гюперзин A

Aisen, P. 2007. A multi- center, double- blind, placebo- controlled therapeutic trial to determine whether natural huperzine A improves cognitive function. Clinical Trials.

Ved, H., M. Koenig, J. Dave, et al. 1997. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. NeuroReport 8(4): 963–967.

Xu, S., Z. Cai, Z. Qu, et al. 1999. Huperzine- A in capsules and tablets for treating patients with Alzheimer disease. Zhongguo Yao Li Xue Bao 20(6): 486–490.

Zhang, R., X. Tang Y. Han, et al. 1991. Drug evaluation of huperzine A in the treatment of senile memory disorders. Zhongguo Yao Li Xue Bao 12(3): 250–252.

Мелатонин

Almeida Montes, L. G., M. P. Ontiveros Uribe, S. J. Cortes, et al. 2003. Treatment of primary insomnia with melatonin: A double- blind, placebo- controlled, crossover study. Journal of Psychiatry & Neuroscience 28(3): 191–196.

Cardinali, D. P, E. Gvozdenovich, and M. R. Kaplan. 2002. A doubleblind placebo-controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly. Neuroendocrinology Letters 23(1): 55–60.

Dowling, G. A., R. L. Burr, E. J. Van Someren, et al. 2008. Melatonin and brightlight treatment for rest- activity disruption in institutionalized patients with Alzheimer’s disease. Journal of the American Geriatrics Society 56(2): 239–246.

Pillar, G., Е. Shahar, N. Peled, et al. 2000. Melatonin improves sleep-wake patterns in psychomotor retarded children. Pediatric Neurology 23(3): 225–228.

Smits, M. G., E. E. Nagtegaal, H. J. van der, et al. 2001. Melatonin for chronic sleep onset insomnia in children: A randomized placebo-controlled trial. Journal of Child Neurology 16(2): 86–92.

Фосфатидилсерин

Crook, T., W. Petrie, C. Wells, et al. 1992. Effects of phosphatidyl-serine in Alzheimer’s disease. Psychopharmacology Bulletin 28: 61–66.

Hellhammer, J., E. Fries, C. Buss, et al. 2004. Effects of soy lecithin phos-phatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress 7: 119–126.

Jorissen, B. L., F. Brouns, M. P. Van Boxtel, et al. 2001. The influence of soy- derived phosphatidylserine on cognition in age- associated memory impairment. Nutritional Neuroscience 4: 121–134.

Palmieri, G., R. Palmieri, M. R. Inzoli, et al. 1987. Double- blind controlled trial of phosphatidylserine in patients with senile mental deterioration. Clinical Trials 24: 73–83.